New glaucoma medications: latanoprostene bunod, netarsudil, and fixed combination netarsudil-latanoprost | Eye
Rhopressa DR 0.02% OPTH SL 2.5ml
Rhopressa: Package Insert - Drugs.com
Rhopressa (netarsudil): Uses, Side Effects, Dosage & Reviews
Rhopressa (netarsudil ophthalmic solution 0.02%) is a Rho kinase (ROCK) inhibitor indicated for the reduction of elevated intraocular pressure in... | By Gustavo Espinoza Oftalmologo | Facebook
Aerie Signs an Exclusive Agreement with Santen for Rhopressa and Rocklatan to Treat Glaucoma or Ocular Hypertension in EU and Other Countries
The Changing Landscape of Glaucoma Therapy
Alcon Buys Aerie in $770 Million Deal, Aims to Boost Sales of Rocklatan, Rhopressa | Market Scope